Low-pass genome sequencing-based detection of absence of heterozygosity: validation in clinical cytogenetics

Zirui Dong, Matthew Hoi Kin Chau, Yanyan Zhang, Zhenjun Yang, Mengmeng Shi, Yi Man Wah, Yvonne K. Kwok, Tak Yeung Leung, Cynthia Morton, Kwong Wai Choy

Research output: Contribution to journalArticlepeer-review


Purpose: Absence of heterozygosity (AOH) is a genetic characteristic known to cause human genetic disorders through autosomal recessive or imprinting mechanisms. However, the analysis of AOH via low-pass genome sequencing (GS) is yet to be clinically available.
Methods: Low-pass GS (4-fold) with different types of libraries was performed on 17 clinical samples with previously ascertained AOH by chromosomal microarray analysis (CMA). In addition, AOH detection was performed with low-pass GS data in 1,639 cases that had both GS and high-probe-density CMA data available from the 1000 Genomes Project. Cases with multiple AOHs (coefficient of inbreeding F ≥1/32) or terminal AOHs ≥5-Mb (suspected uniparental disomy) were reported based on guidelines of the American College of Medical Genetics and Genomics.
Results: Low-pass GS revealed suspected segmental UPD and multiple AOHs (F≥1/32) in nine and eight clinical cases, respectively, consistent with CMA. Among the 1,639 samples, low-pass GS not only consistently detected multiple AOHs (F≥1/32) in 18 cases, but also reported 60 terminal AOHs in 44 cases including four mosaic AOHs at a level ranging from 50% to 75%.
Conclusion: Overall, our study demonstrates the feasibility of AOH analysis (≥5-Mb) with low-pass GS data and shows high concordance compared with CMA.
Original languageEnglish
JournalGenetics in Medicine
Publication statusAccepted/In press - 1 Feb 2021


Dive into the research topics of 'Low-pass genome sequencing-based detection of absence of heterozygosity: validation in clinical cytogenetics'. Together they form a unique fingerprint.

Cite this